Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
PerkinElmer Inc | PKI | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
115.24 | 115.24 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 114.2875 - 132.54 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 115.24 | USD |
PerkinElmer Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
12.66B | 123.41M | - | 2.75B | 693.09M | 5.62 | 18.27 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
PerkinElmer News
Date | Time | Source | News Article |
---|---|---|---|
4/29/2024 | 07:40 | Edgar (US Regulatory) | Form 8-K - Current report |
4/24/2024 | 15:06 | Edgar (US Regulatory) | Form 8-K - Current report |
4/16/2024 | 15:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
3/27/2024 | 15:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
3/21/2024 | 15:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
3/13/2024 | 07:05 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders |
3/13/2024 | 07:02 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
3/13/2024 | 07:01 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
5/11/2023 | 05:00 | Business Wire | Revvity Announces Financial Results for the First Quarter of.. |
5/09/2023 | 07:00 | Business Wire | Launching Revvity: A Scientific Solutions Company Powering.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PKI Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 130.86 | 132.54 | 114.2875 | 122.83 | 974,302 | -15.62 | -11.94% |
3 Years | 130.89 | 203.16 | 113.46 | 153.88 | 814,477 | -15.65 | -11.96% |
5 Years | 95.92 | 203.16 | 62.91 | 130.03 | 834,624 | 19.32 | 20.14% |
PerkinElmer Description
PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software. |